Abstract
Tibial cortex transverse transport (TTT) surgery is an extension of the Ilizarov technique. Based on the law of tension‐stress, its primary function is to rebuild microcirculation which can relieve ischemic symptoms and promote wound healing. It has received more and more scholars' attention and has experienced a series of changes for 20 years since it entered PR China. The mechanisms involved have gradually become clear, such as the reconstruction of the polarization balance of macrophages, the promotion of vascular tissue regeneration, and the mobilization and regulation of bone marrow‐derived stem cells. TTT technique is mainly used in the treatment of chronic ischemic diseases of the lower extremities. It has recently been successfully used in the treatment of primary lymphedema of the lower extremities. A series of improvements have been made in the external fixator's style, the size of skin incision and osteotomy, and distraction method. For example, the annular external fixator has been redesigned as a unilateral external fixator, and accordion technology has been introduced. For distraction methods after surgery, there was no uniform standard in the past. The technique can also be used in combination with other treatments to achieve better effects, such as interventional therapy, negative pressure sealed drainage, 3D printing technology, traditional Chinese medicine. Nevertheless, the surgery may bring some complications, such as secondary fracture, nail infection, skin necrosis at the surgical site, etc. Reports of complications and doubts about the technique have made the TTT technique controversial. In 2020, the relevant expert consensus was published with treatment and management principles, which might guide the better application and development of this technique.
Keywords: Ilizarov technique, improvement, microcirculation, tibial cortex transverse transport, wound healing
The surgery of tibial transverse transport has shown definite efficacy in the treatment of chronic ischemic diseases of the lower extremities and may be gradually applied to the treatment of primary lymphedema in the future. With the gradual understanding of its mechanism of action, the continuous improvement of the technique, and the publication of relevant expert consensus, its clinical application will be further guided.
Introduction
Tibial cortex transverse transport (TTT) is a continuation of the Ilizarov technique. Unlike the previous Ilizarov external fixation technique for longitudinal movement of the osteotomy segment, this operation involves lateral distraction of a bone chip on the tibial shaft. The purpose of TTT is not osteogenesis but local vascular tissue regeneration. Based on the law of stress‐tension, the continuous distraction of the tibial cortex chip can promote cell metabolism, accelerate tissue regeneration, rebuild microcirculation, and restore blood and oxygen supply to the lower limbs. It is now mainly used in the treatment of chronic ischemic diseases of the lower extremities 1 . Recently, TTT has been successfully used in the treatment of primary lymphedema in the lower limb 2 .
China's Qu et al. 3 first applied TTT to the clinic in China. They published the article “The Therapy of Transverse Tibial Bone Transport and Vessel Regeneration Operation on Thromboangitis Obliterans” in 2001, which not only introduced TTT to PR China but also opened up the exploration of TTT by Chinese scholars. By 2021, the technique has been developed in PR China for a full 20 years. Its indications expanded from thromboangiitis obliterans to chronic ischemic diseases of the lower extremities, including diabetic foot ulcers, thromboangiitis obliterans, and arteriosclerotic obliterans, especially diabetic foot ulcers. Looking back at the past 20 years, TTT has been paid more and more attention, applied and studied by more and more scholars. As the use of the TTT has increased, reports of complications have increased. Many patients and even doctors have a hard time understanding how the technique works: patients with chronic ischemic diseases of the lower extremities have an insufficient blood supply and poor wound healing ability, and how can TTT surgery, an invasive treatment, achieve the purpose of restoring blood supply of lower extremities and promoting wound healing? Reports of complications and doubts about the technique have made it controversial.
In order to enable more people to know this technique, understand its mechanism of action, current application fields, and efficacy and safety, while at the same time allowing the technique to be better developed for clinical application, this paper reviews the 20‐year research progress of this technique since it was introduced into PR China.
Methods
Three databases were searched, including PubMed, CNKI, and Wanfang databases. The literature about TTT published before March 2021 was searched with the following keywords: “lateral tibial transport,” “transverse tibial transport,” “transverse tibial movement,” “transverse bone transport,” “tibial bone immigration,” “tibial transverse transport,” “distraction osteogenesis,” “Ilizarov technique,” “Ilizarov bone transport,” and so on.
The inclusion criteria were: (i) content of literature is related to TTT surgery; (ii) articles can come from journals, dissertations, and conference reports, but the content must be complete; (iii) the types of articles can be randomized controlled studies, case reports, and reviews, etc.; and (iv) for clinical research articles, patients need to receive TTT surgery, which can be compared with conventional treatment or TTT alone, and the postoperative results must be reported.
The exclusion criteria: (i) low evidence level; (ii) unable to obtain full text; and (iii) the language of the text is neither Chinese nor English.
According to the inclusion criteria and exclusion criteria, two independent reviewers filtered those articles; a third reviewer would mediate when inconsistent judgment appeared. Subsequently, the qualified articles were carefully read to summarize the mechanism of action, application fields, improvement of surgical procedures in recent years, efficacy and safety, as well as the first expert consensus published recently. A total of 80 articles were eventually cited in the review.
Results
Mechanism of Action
Law of Tension‐Stress
Ilizarov, a doctor from the former Soviet Union, found that if the broken end of fracture and the long epiphyseal end is continuously and steadily distracted slowly, it can stimulate the regeneration of bone tissue, which is called “distraction osteogenesis” 4 . Further basic and clinical research led to forming the “law of tension‐stress”: a slow, steady, continuous distraction on living tissue stimulates local tissue regeneration and active growth. Ilizarov originally developed the TTT external fixator to thicken the bone and change its shape but unexpectedly found that the lower limbs' blood flow increased significantly 5 . Then, he performed TTT surgery on the dog's tibia, then distracted bone chip for 3 weeks and saw successful regeneration of the capillary network 6 . However, he did not conduct additional clinical research on the regeneration of vascular and tissue. Today, the goal of TTT is not intended to osteogenesis or change the shape of the tibia but to regenerate tissue, rebuild local microcirculation, and eventually restore blood and oxygen supply to the lower extremities 7 .
Reconstruction of Polarization Balance of Macrophages
Wound healing mainly includes three stages: inflammation, proliferation, and remodelling 8 , 9 , 10 , 11 . Macrophages are the key to the transition from the inflammatory phase to the proliferative phase, and they can be divided into two types. M1 type macrophages can secrete various pro‐inflammatory factors to kill pathogenic microorganisms and control infection, but at the same time can cause damage to normal tissue. M2 type macrophages can secrete various anti‐inflammatory and growth factors to regulate immune response and promote repair of tissue damage 12 , 13 . Gao et al. 14 thought that the persistent existence of pathogenic microorganisms, which led to the macrophage polarization in the wound of severe diabetic foot ulcers, was unbalanced. Macrophages are mainly polarized into M1, while M2 is relatively deficient. Those may be the reason why the wound healing is prolonged. They observed tissue sections of wounds from patients after TTT and compared macrophage types, finding that the number of macrophages decreased 1 month after surgery. Meanwhile, the M1/M2 ratio decreased from 4.072 ± 0.502 before surgery to 3.098 ± 0.548 (P < 0.05) (Table 1). Therefore, they hypothesized that TTT could control the local wound inflammation, tend to make macrophages transform into M2 type, promote the reconstruction of macrophage polarization balance and anti‐inflammatory function, and finally heal the wound. There are limited studies on the reconstruction of the polarization balance of macrophages by TTT, and the specific role of TTT in this process can be further explored.
TABLE 1.
Sample size | Pre‐surgery | 1 month after TTT surgery | P value | |
---|---|---|---|---|
Count of M1 | 10 | 156.270 ± 33.034 | 73.930 ± 15.065 | <0.001 |
Count of M2 | 10 | 39.900 ± 11.120 | 28.950 ± 8.774 | 0.025 |
M1/M2 | 10 | 4.072 ± 0.502 | 3.098 ± 0.548 | 0.001 |
Abbreviations: M1, M1 type macrophages; M2, M2 type macrophages; M1/M2, the ratio of M1 to M2; TTT, tibial cortex transverse transport.
Promotion of the Regeneration of Vascular Tissue
TTT aims to rebuild the microcirculatory system and improve ischemia, so the wound is expected to heal with nutritional supply. Due to the long‐term inflammatory phase of the patient's wound, angiogenesis is difficult 15 . To facilitate the healing process, the critical issue to be addressed at this stage is angiogenesis. Lian et al. 16 found that the expression levels of Ki‐67, platelet endothelial cell adhesion molecule‐1 (CD31), and vascular endothelial growth factor (VEGF) in marginal tissues of wound increased significantly 1 month after TTT surgery compared to pre‐surgery (Table 2). The increase in Ki‐61 reflects the enhancement of local cell proliferation. CD31 participates in signal transduction, promotes tissue angiogenesis, and maintains the integrity of vascular endothelial cells 17 , 18 . VEGF can promote angiogenesis 19 , 20 , 21 . Therefore, they hypothesized that surgery could effectively promote cell proliferation and capillary regeneration in local tissues. Ou et al. 22 studied the expression of angiogenesis‐related growth factors in patients' serum and reached a consistent conclusion. They revealed that VEGF, basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) expression levels were not significantly increased until the seventh day after the distraction and remained higher than preoperative levels until the end of distraction. Platelet‐derived growth factor (PDGF) expression level increased suddenly 2 weeks after the operation and remained high until the end of distraction (Figure 1). Both bFGF and EGF can promote cell proliferation and epithelialization of granulation tissue 23 . PDGF can promote debridement and repair 24 . This difference in expression level may be because distraction promotes vascular tissue regeneration in the initial stage and plays a repair role later. At present, observed growth factors are limited. Whether the expression levels of other kinds of growth factors also change due to TTT needs further study.
TABLE 2.
Sample size | Percentage of positive cell area | Z value | P value | ||
---|---|---|---|---|---|
Pre‐surgery | 1 month after TTT surgery | ||||
Ki‐67 | 30 | (1.850 ± 1.287) % | (7.480 ± 5.272) % | 3.292 | 0.001 |
CD31 | 30 | (0.395 ± 0.139) % | (1.082 ± 0.636) % | 3.403 | 0.001 |
VEGF | 30 | (0.341 ± 0.217) % | (2.428 ± 1.502) % | 3.780 | 0.000 |
Abbreviations: CD‐31, platelet endothelial cell adhesion molecule‐1; VEGF, vascular endothelial growth factor; TTT, tibial cortex transverse transport.
Mobilization and Regulation of Bone Marrow‐Derived Stem Cells
The osteotomy site is mainly in the middle and upper segment of the tibia, but the foot lesions and ulcers can heal after distraction. Hua et al. call this phenomenon the “summoning phenomenon” 25 . Some patients have ulcers in both lower extremities. After unilateral bone transport, contralateral ulcers, skin temperature, blood supply, and pain have also been influenced to a certain extent 26 , 27 . These phenomena suggest that the effect of TTT may be systemic, which is similar to the mechanism of stem cell repair: stem cells can migrate to the site of injury, restore vascular endothelial function, promote vascular tissue regeneration, and heal wounds. Bone marrow is the largest stem cell bank in the body. Xiang 28 found a significant increase in the number of hematopoietic stem cell colony formations in patients' serum 1 month after surgery (Table 3), which might be due to TTT mobilizing bone marrow‐derived stem cells. The expression level of the PI3K/ AKT signaling pathway was increased in patients' serum 1 month after surgery (Table 3), which might because TTT further activated the stromal cell‐derived factor 1 (SDF‐1)/ CXC chemokine receptor 4 (CXCR4) axis and PI3K/ AKT signaling pathway, as well as regulated the migration and functional differentiation of bone marrow‐derived stem cells to the injury site and promoted the repair and regeneration of skin, blood vessels, nerves, etc.
TABLE 3.
Sample size | Pre‐surgery | 1 month after TTT surgery | t value | P value | |
---|---|---|---|---|---|
Count of BFU‐E | 20 | 46.20 ± 7.43 | 74.95 ± 9.63 | 10.568 | <0.05 |
Count of CFU‐GM | 20 | 5.55 ± 1.54 | 10.60 ± 2.16 | 8.512 | <0.05 |
Count of PI3K | 20 | 1.00 ± 0.18 | 2.19 ± 0.51 | 10.365 | 0.000 |
Count of AKT | 20 | 1.00 ± 0.21 | 2.27 ± 0.59 | 9.840 | 0.000 |
Abbreviations: AKT, protein kinase B; TTT, tibial cortex transverse transport; BFU‐E, burst forming unit erythroid; CFU‐GM, colony‐forming unit‐granulocyte, macrophage; PI3K, phosphatidylinositol 3‐kinase.
Lian 29 found that the expression level of stem cell mobilization‐related chemokines in diabetic patients such as SDF‐1 was significantly up‐regulated 1 month after surgery compared with that before surgery (fold change:1.307113), suggesting that bone marrow‐derived stem cells were mobilized. It was also speculated that the continuous distraction caused by TTT would continuously stimulate and activate the SDF‐1/CXCR4 pathway, which could produce a long‐lasting effect. Vu Le Hoang Anh 30 measured the SDF‐1 level in serum of patients before surgery, 1 month after surgery, and 3 months after surgery. The distraction period was 4 weeks. The SDF‐1 level in serum was significantly increased 1 month and 3 months after surgery than before surgery (Table 4). But the level of SDF‐1 in serum at 3 months after surgery was lower than that at 1 month after surgery. The difference of SDF‐1 expression levels in patients' serum at different stages has confirmed that the mobilization effect of bone marrow‐derived stem cells is indeed continuous.
TABLE 4.
Sample size | SDF‐1 (pg/ml) | |
---|---|---|
Pre‐surgery | 16 | 220.19 ± 16.72 a |
1 month after TTT surgery | 12 | 368.46 ± 21.32 |
3 months after TTT surgery | 10 | 318.22 ± 12.61 |
Abbreviation: SDF‐1, stromal cell‐derived factor‐1; TTT, tibial cortex transverse transport
Compared to other times, P < 0.05.
Application Fields
Chronic Ischemic Diseases of the Lower Extremities
After TTT was introduced into PR China, it was first used by Qu et al. 3 for the treatment of thromboangiitis obliterans, then by Wang et al. 31 for the treatment of arteriosclerosis obliterans, and later widely used for the treatment of diabetic foot 32 , 33 , 34 . These diseases have different etiology, but their progression can lead to microcirculation disorders and chronic ischemic symptoms: claudication, rest pain, ischemic ulcers or gangrene, and in severe cases, amputation 15 , 32 , 35 . In the early stage, drugs can be used to dilate blood vessels, reduce lipids, and improve coagulation function. In severe cases, arterial access reconstruction, surgical debridement, and infection control can be performed 36 . However, these treatment methods' overall efficacy is not satisfactory, and the disease may occur repeatedly or even continue to progress, and the ulcers wound is difficult to heal. The TTT technique can improve ischemia, relieve pain, heal and repair wounds, and significantly improve the percentage of limb salvage by distraction. Therefore, it is mainly applied in the treatment of chronic ischemic diseases of lower extremities in PR China.
Besides, Yang et al. 37 used this technique to treat 12 elderly patients with chronic foot ulcers, of which 11 patients healed and one patient's food was amputated. Nie et al. 38 treated 42 cases of recalcitrant non‐diabetic leg ulcers, and compared with traditional treatment, TTT could facilitate the ulcer healing and reduce the healing time. It can be seen that TTT has a definite therapeutic effect on the wound caused by chronic ischemia.
Primary Lymphedema in the Lower Extremities
Lymphedema is a chronic disease. Primary lymphedema is caused by congenital disorders of lymphatic circulation, leading to symptoms such as pain, limb swelling, and skin tightness, etc. Complete decongestive therapy is a common form of physical therapy and basic treatment. However, the high technical requirements for physicians, nurses, and physical therapists make it challenging to apply this method. Surgical treatment, such as lymphatic‐lymphatic anastomosis or lymphatic‐venous anastomosis, can also be turned to, but surgery's difficulty is relatively great. No matter what kind of treatment is taken, the disease tends to relapse, and the cure rate is low 39 . Zhu et al. 2 presumed that TTT, which can improve the blood circulation of limbs, could possibly improve the function of the lymphatic system, so they tried to use TTT to treat a patient with primary lymphedema of the right lower extremity who suffered edema, tight skin, and aching of the lower limb. The patient's pain was significantly relieved after surgery, and the lower extremity edema gradually subsided. There was no recurrence of edema during the 10‐month follow‐up after surgery.
TTT technique has no direct relationship with the lymphatic system, but it can improve the lymphatic circulation function and treat primary lymphedema. The mechanism remains unclear, and only one case has been reported so far. Whether this technique can be used as a novel method for treating primary lymphedema still needs more case studies and longer follow‐up to clarify long‐term efficacy. Meanwhile, it also means that there may be more potential TTT value that has not been discovered, which is worth exploring.
Improvements in Tibial Cortex Transverse Transport Technique
When foreign scholars applied this technique, they used the traditional annular external fixator 40 , 41 (Figure 2A). Corticotomy was performed on the lateral surface of the tibia. Transverse incisions were 3 cm long, crossing the tibial crest, and mainly lateral. The longitudinal incisions were about 12 cm. The drill was used to drill holes, and then a bone knife was used to form a rectangular bone chip. Three olive wires equidistant to each other were used to pass through the rectangular piece's lateral cortex from the medial incision. The distal end of the olive wire was connected to Ilizarov external fixator with the slotted threaded rod. The distraction was started after 1 week: 1 mm per day till a distraction of 20 mm was achieved.
Exploration of Surgical Procedures
Qu et al. 3 redesigned a unilateral external fixator when the TTT technique was applied for the first time in PR China (Figure 2B). They altered the osteotomy area into the medial side of the tibial crest and changed three olive wires into two curved steel needles. A 15‐cm longitudinal incision was made on the medial skin of the middle segment of the tibia. A pneumatic saw was used to penetrate the bone cortex to form a corticotomy window of 12 cm × 2 cm, and the bone marrow should be protected during this process. Two curved steel needles passed through the cortex and then assembled the external fixator. The distraction was started after 5 days: 1 mm per day, divided 15–20 times, till a distraction of 22 mm was achieved. The unilateral fixator is smaller than the annular fixator and thus can reduce trauma. Some scholars thought that the advantages of selecting corticotomy on the tibia's anteromedial surface were that the medial approach could avoid injury to the common peroneal nerve and the flat surface here was easier for corticotomy 42 .
In reports of Hua et al., they selected the middle and upper segment of the tibia for cortical osteotomy, where the circumference is longer, to reduce the risk of fracture 32 , 43 , 44 . The periosteum was cut longitudinally and opened entirely to both sides to expose the corticotomy area. A pneumatic saw was used to form a corticotomy window. Two 2‐mm threaded needles were used for distraction (Figure 2C). The distraction was started after 5 days: 1 mm per day, divided 4 times, for 21 days, and then the bone chip was moved back in place at the same speed (accordion technology). External fixation was kept for 4 weeks, and the external fixator could be removed if callus formation was found on reexamination radiographs.
The medial‐then‐lateral movement of a bone chip, just like the use of an accordion, is called accordion technology. This non‐invasive technique is based on the law of tension‐stress 45 and does not require injecting any drugs, proteins, or growth factors 46 . Before accordion technology was introduced into TTT surgery, it has been applied to deal with delayed union or nonunion after treatment of bone defect or infection with Ilizarov external fixation. Studies have proven that compression, distraction, and recompression of the broken end of fracture can regulate the growth factors and signaling pathways related to osteogenesis in the human body, thus stimulating the formation of microcirculation and promoting bone healing 45 . Introducing accordion technology into the TTT technique has the following advantages: the combination of median and lateral transport patterns can return the bone chip to its original position, avoiding humps on the surface of the tibia, and prolong the distraction time persistently stimulating the formation of microcirculation. Hua et al. utilized threaded needles that allowed the bone chip to be moved in the opposite direction enabling “accordion technology” and made it easy to remove. So, this is a significant innovation.
The medial tibia's skin tissue is thin, and the blood supply is insufficient, so the wound is difficult to recover and susceptible to infection. Researchers have been trying to make skin incisions or corticotomy sizes smaller (Figure 3). Yang et al. 47 shortened the incision to 8–10 cm, and the corticotomy size was still 10 cm × 2 cm. Yang et al. 48 improved the surgical incision to three smaller incisions with a distance of 2 cm and a length of 1.5 cm, while Ou et al. 49 used the same method, but the incision size was 3 cm. They both kept the size of the corticotomy unchanged. In this way, the surgical trauma was reduced while the surgical field exposed, thereby reducing the occurrence of adverse complications. From another perspective, Cen et al. 26 reduced the incision of the medial tibia to 3 cm and then used a microporous osteotomy apparatus to make a 5 cm × 1.5 cm bone chip. Both the incision and osteotomy areas were reduced, but the clinical efficacy was not affected.
Vu Le Hoang Anh 30 reported that two curved incisions of 2.5 cm were made with a 3 cm medial interval in the middle of the tibia. Bone windows of 3.5 cm × 1.5 cm were made at an interval of 2 cm below the two incisions, respectively, which was called “日”‐type osteotomy. A 4‐mm traction needle was screwed into each of the two bone chips to distract them. A review of related studies shows that “日”‐type osteotomy is less commonly used. Simply reducing the osteotomy area can still obtain a good effect. In contrast, the “日”‐type osteotomy is complicated, increasing the trauma and prolonging the operation time. Maybe that is why 5 cm × 1.5 cm bone windows are preferred clinically.
When Qu et al. 3 first used this technique in PR China, they emphasized that bone marrow should be protected during corticotomy so as not to affect the regeneration of intramedullary tissue. Later, Cheng et al. 50 added that the periosteum should also be protected. Jia et al. 51 used “门”‐type window opening to retain the periosteum of the fibula side and then opened the periosteum and inserted the needles. It has been reported that the periosteum can promote the regeneration of the local microvascular network 52 . The animal experiments conducted by Cao et al. 53 confirmed that compared with the traditional “rectangular” window opening, the “门”‐type window opening significantly increased the peripheral blood vessel area and the percentage of vascular endothelial cells was significantly higher. So, the periosteum protection can provide a suitable environment for the subsequent regeneration of the microvasculature network.
Exploration of Postoperative Management
There is much variability in how long it takes to start distraction after surgery. Li et al. 54 began on the second day after surgery. Zhang et al. 55 took X‐rays for reexamination 5–7 days after the operation and started distraction according to the wound condition. Some researchers 56 , 57 , 58 waited at least 1 week after surgery before starting. Qu et al. 3 advocated starting the distraction at least 5 days after surgery. Jia et al. 51 thought that the possible explanations were as followed: First of all, as the soft tissue on the inner side of the tibia is thin and the blood supply is insufficient, performing the distraction immediately after surgery is unfavorable for healing. Secondly, delayed movement is helpful to the healing of the periosteum. Then, the formation of the tibial bone window will reduce the intramedullary pressure, leading to the release of local microvascular spasm and increased bleeding, so early movement may increase bleeding. Last but not least, delayed movement avoids pain in the surgical area. Although the timing of the onset of distraction is different in the current study, no randomized controlled clinical study has determined this factor's effect on efficacy.
There was also no uniform standard for the speed and duration of distraction. At first, Qu et al. 3 used 1 mm per day, divided 15–20 times, till a distraction of 22 mm was achieved. Hua et al. 32 introduced the “accordion technology” and distracted 1 mm per day, divided 4 times, medial transport for 3 weeks and then lateral transport for 3 weeks. Besides, 1 mm per day, divided 4 times, for 10 days, and then moved back 59 1 mm per day, divided 5–8 times, for 2 weeks, and then moved back 57 . Medial transported for 7 days and lateral transported for 7 days, then repeat medial transported for 7 days and lateral transported for 7 days 60 . Sun et al. 61 started distraction 1 mm per day, divided 3–4 times. If the patient had pain or other discomforts, the distraction should be suspended for 1–2 days or changed to 0.5 mm per day, and the duration of the whole transport was 14–16 days. Ye et al. 62 also pointed out that transport speed and distance should be determined according to the skin condition. As for how long the distraction lasts, at what rate, and how many rounds of distraction can bring the most excellent benefits, the current selection is mainly based on experience. There is a lack of relevant research, which is worth exploring.
Combined Application of Tibial Cortex Transverse Transport Technique
Wang et al. 63 indicated that TTT could only rebuild the microcirculation system from the perspective of vascular surgery. It is not easy to achieve the expected effect if the large and middle arteries cannot be guaranteed to have sufficient blood flow. The limitation of the TTT technique prompted scholars to break through the restriction by combining other technologies, which achieved satisfactory results.
For example, femoral‐femoral artery bypass grafting combined with TTT 58 , or interventional therapy combined with TTT 64 , was used for severe vascular occlusion in the lower extremities. These treatments unclog the blocked blood vessels, restore blood supply to the lower extremities, and restore microcirculation. Negative pressure sealed drainage 51 , 65 , 66 , or antibiotic‐embedded bone cement 67 combined with TTT can control infection and increase local blood supply, jointly promoting wound healing. The 3D printing technology is used to make individualized surgical guide plates, which can accurately point and orient in operation according to the planned digging range, needle insertion position, and angle, reducing operation time and blood loss 57 . Autologous platelet‐rich plasma combined with TTT can effectively shorten the wound healing time and reduce complications 68 , 69 , 70 . Platelet‐rich plasma is an emerging technique in recent years. Although it has been reported to have specific effects, it has a high cost and requires repeated use during treatment. Whether it can bring exact benefits to patients remains to be studied. Some traditional Chinese medicines can also be used after surgery, which may be an excellent complementary and intensive treatment for TTT 71 , 72 . Traditional Chinese medicine treatment based on syndrome differentiation has unique advantages, relatively low cost, and high patient acceptance, worthy of clinical research.
Clinical Efficacy and Safety
Xu et al. 73 reported that TTT was used to treat 35 cases of thromboangiitis obliterans. Thirty‐two patients successfully regenerated the blood vessels, their rest pain and intermittent claudication were significantly relieved. Histopathological examination performed on two of the 32 effective patients 2 months after surgery showed that the vascular endothelial cells in the vascular regeneration area were actively dividing and proliferating. Many capillaries and arterioles were born with the lumen unobstructed. Angiography performed 3 months after surgery in 12 patients showed a web of new arterioles emerging from the distraction area to the foot. Skin necrosis occurred in two cases, and nail infection occurred in four cases, which were cured after symptomatic treatment. Hu et al. 74 treated 66 cases of thromboangiitis obliterans, and the skin temperature and blood oxygen saturation of the toe on the operated side increased significantly 2 months after surgery. Yang et al. 48 treated 52 cases of thromboangiitis obliterans, and after 2–3 years of follow‐up, 45 cases of ulcers and wounds were successfully healed, with a total effective rate of 87%. Seven cases were amputated due to skin necrosis at the surgical incision or aggravation of ischemia, including five cases of popliteal artery embolization and two cases of posterior tibial artery embolization. The reason for the failure of these cases is that microcirculation is severely impaired, and it is difficult to regenerate. Therefore, the patency of the popliteal artery is essential for successful bone transport.
Hua et al. has used the TTT technique to treat diabetes since 2013. There have been more than 516 patients with an average follow‐up of 32 months, and the limb salvage rate is 96.1% (Figure 4). One hundred and thirty‐six cases were followed up for 2 years. Four cases were amputated. Four cases had a relapse, and two cases had recrudescence 25 . Tian et al. 75 conducted a meta‐analysis on the efficacy and safety of the TTT technique in treating diabetic feet. Compared with conventional treatment, TTT can significantly relieve pain, increase skin temperature, shorten ulcer healing time, improve the healing rate, and reduce amputation and recurrence rate. Common postoperative complications include tibial fracture, nail infection, non‐healing wound, tibial deformity, osteomyelitis caused by the wrong move of the bone chip, etc. However, the incidence of complications is low, showing reliable safety. It should be pointed out that the number of pieces of literature included in this study was limited, so the conclusions need to be confirmed by more clinical studies. Zhang et al. 76 retrospectively analyzed 196 cases of diabetic foot treated by TTT, and 41 patients developed complications. Among them, there were 18 cases of nail infection, 12 cases of skin necrosis in the corticotomy area, and nine cases of tibial shaft fracture, all of which healed after symptomatic treatment (Figure 5). Two patients underwent amputation due to persistent foot infection and gangrene. Qin et al. 77 applied this technique alone in the treatment of 19 patients with diabetic foot. Their pain was significantly relieved after the operation, but the blood circulation and nerve function were not significantly improved. The ulcer's healing rate was only 47.4%, and there were two cases of recurrence, which was quite different from most reported results. Fan et al. 78 also pointed out that the function of TTT should not be exaggerated, and the complications brought by surgery should not be ignored. TTT alone cannot achieve the therapeutic purpose entirely, and debridement, wound care, anti‐infection, and other measures are also of great significance. (The clinical efficacy and complications of some studies are shown in Appendix Table A1.)
TABLE A1.
Author | Disease | Sample size | Results | Efficacy | Amputation | Complications | Follow‐up |
---|---|---|---|---|---|---|---|
Qu 5 | Thromboangiitis obliterans | 18 | Skin temperature increased, numbness disappeared, symptoms of intermittent claudication relieved, and angiography revealed an extremely rich network of blood vessels around the bone chip in the distal leg. | 18 (100%) | 0 | No description | 3 months |
Hua et al. 25 | Diabetic foot | 516 | Rest pain relieved and blood flow to the feet increased significantly. | 496 (96.12%) | 20 |
Incision infection or skin necrosis (7) Secondary fracture (6) Acute arterial embolism (2) |
7–72 months 11 cases recurred |
Cen et al. 26 | Diabetic foot | 130 | Skin temperature increased, VAS score decreased, histological examination showed a decrease in inflammatory cells and an increase in myocytes, CT angiography showed a significant increase in collateral circulation. | 124 (95.38%) | 2 | Wound nonhealing (6) | 4–34 months |
Yang et al. 37 | Chronic ulcers in the elderly | 12 | Skin temperature increased, the ankle‐brachial index improved, and CRP, ESR, and WBC indexes decreased. | 11 (91.67%) | 1 | No description | / |
Yang et al. 47 | Diabetic foot | 8 | Skin temperature increased, VAS score decreased, CT angiography in the operated limb showed that the dorsal foot artery was clear, the calf artery was open, the collateral artery was increased, the blood flow rate was faster, and the circulation was improved. | 8 (100%) | 0 | 0 | 1–3 months |
Yang et al. 48 | Thromboangiitis obliterans | 52 | Skin temperature increased, VAS score decreased, the ulcers healed, angiography revealed many new small arteries in the distal tibia, interwoven into a network and extended laterally and diagonally to the muscle and subcutaneous tissue. | 45 (86.54%) | 7 |
Massive cerebral embolism (1) Nail infection (3) Deep vein thrombosis in lower limbs (1) |
2–3 years Three patients recurred and underwent surgical treatment again |
Ou et al. 49 | Diabetic foot | 23 | Skin temperature increased, VAS score decreased, Barthel index score increased. | 21 (91.30%) | 1 | Fat liquefied at the incision (3) | 12–19 months |
Cheng et al. 50 |
Diabetic foot Thromboangiitis obliterans |
21 | Rest pain and peripheral neuropathy relieved, skin temperature increased, the ulcers healed, WBC count and erythrocyte sedimentation rate decreased. | 20 (95.24%) | 1 | Surgical site infection (1) | 3–15 months |
Jia et al. 51 | Diabetic foot | 19 | The ankle‐brachial index increased, Michigan Neuropathy Screening Instrument (MNSI) decreased, angiography or vascular ultrasound demonstrates microvascular network regeneration in the affected feet. | 17 (89.47%) | 0 |
Nail infection (2) Secondary fracture (2) Severe pneumonia (1) |
3–13 months |
Li et al. 54 | Diabetic foot | 21 | The ankle‐brachial index increased, the ulcers healed, and vascular ultrasound found increased blood flow in the affected feet' anterior and posterior tibial arteries. | 21 (100%) | 0 | Severe ulcer infection on the contralateral foot (1) |
13–24 months One patient died 13 months after surgery due to systemic sepsis due to severe ulcer infection on the contralateral foot |
Zhang et al. 55 | Diabetic foot | 10 | Resting pain relieved, skin temperature increased, the ulcers healed. | 10 (100%) | 0 | 0 | 3 months–1 year |
Liu et al. 57 | Diabetic foot | 11 | VAS score decreased, skin temperature increased, numbness disappeared. | 11 (100%) | 0 | No description | 3–24 months |
Ding et al. 59 | Diabetic foot | 12 | VAS score decreased, skin temperature and ankle‐brachial index increased, the test results of 10g nylon line improved, CT angiography showed increased collateral arteries, and dorsal foot arteries thickened. | 12 (100%) | 0 | 0 | 5–10 months |
Wang et al. 63 |
The chronic ischemic disease of lower limbs: Diabetic foot (41) Arteriosclerosis obliterans (14) Thromboangiitis obliterans (4) |
59 | VAS score decreased, skin temperature and ankle‐brachial index increased, CT angiography showed recanalization of the inferior knee anterior tibial artery branches. | 54 (91.53%) | 4 |
Skin necrosis (2) Osteomyelitis (1) |
8 weeks–25 months Ulcer recurrence (4) The vessel occluded again (4) |
Lu et al. 65 | Diabetic foot | 45 | VAS score decreased, skin temperature and ankle‐brachial index increased, the color ultrasonography revealed collateral branches of arteries in the leg increased, with a clear presentation of the pedis arteries. | 45 (100%) | 0 |
Nail infection (1) Deep vein thrombosis in lower limbs (1) Surgical incision infection (1) Pulmonary infection (1) |
12–14 months ulcer recurrence (3) |
Wang et al. 67 |
The chronic ischemic disease of lower limbs: Diabetic foot (25) Arteriosclerosis obliterans (2) Thromboangiitis obliterans (1) |
28 | Resting pain relieved, the ulcers healed. | 25 (89.29%) | 1 |
Needle reaction of external fixator (not infection) (21) Pulmonary infection (1) Acute lower extremity vascular embolism (1) Secondary fracture (1) |
5–27 months |
Zhao et al. 72 | Diabetic foot | 32 | VAS score decreased, skin temperature increased, the blood flow velocity of dorsal foot artery increased, total peroneal nerve sensation and motor conduction velocity improved, peripheral blood VEGF and PDGF level increased. | 32 (100%) | 0 | Secondary fracture (1) |
4–9 months Ulcer recurrence (1) |
Xu et al. 73 | Thromboangiitis obliterans | 35 | resting pain and intermittent claudication relieved, skin temperature increased, tissue necrosis decreased, angiography revealed numerous new arterioles extending into the muscle and subcutaneous tissue, pathological examination showed obvious division and hyperplasia of vascular endothelial cells and smooth intima of arterioles. | 32 (91.43%) | 3 |
Cerebral fat embolism (1) Skin necrosis (2) Nail infection (4) |
2–6 years |
Hu et al. 74 | Thromboangiitis obliterans | 66 | VAS score decreased, skin temperature and toe oxygen saturation increased, and angiography revealed new arterioles emerging below the surgical site. | 64 (96.97%) | 0 | No description | 2 months |
Qin et al. 77 | Diabetic foot | 19 | VAS score decreased, skin temperature and ankle‐brachial index increased insignificantly. | 9 (47.37%) | 2 |
Secondary fracture (2) Nail infection (5) The tibia exposed (1) |
12–16 months Ulcer recurrence (2) |
Yang et al. 80 | Thromboangiitis obliterans | 20 | VAS score and claudication distance decreased, skin temperature and ankle‐brachial index increased. | 18 (90%) | 2 |
Ischemia aggravated (1) Osteotomy infection (1) |
14–69 months |
Formation of Expert Consensus on the Tibial Cortex Transverse Transport Technique
TTT technique was born at the end of the last century and has not been widely used globally yet. Chinese researchers have been exploring it for two decades and have gained some experience in the treatment. Simultaneously, the technique has been doubted because of its complications and the fact that it is entirely different from traditional therapies. After 20 years of development, this technique has proved to be an effective way to treat chronic ischemic diseases in the lower extremities, especially in the treatment of the diabetic foot. The Chinese Association of Orthopaedic Surgeons, Taskforce Group of Tibial Cortex Transverse Transport Technique for the Treatment of Diabetic Foot Ulcers was established in 2019. Together with experts in various fields, they published “Expert Consensus on the Treatment of Diabetic Foot Ulcers Using Tibial Transverse Transport (2020)” in 2020 79 , which proposed the following treatment and management principles.
No tourniquet is applied after anesthesia to protect blood supply to the lower extremity. The corticotomy site shall be 5 cm below the tibial tuberosity on the medial tibia. A 3‐5‐cm arc incision is made, or multiple 1‐cm incisions perpendicular to the outer edge of the corticotomy area. An osteotomy device is used to make a 5.0 cm × 1.5–2.0‐cm bone chip without dissecting the periosteum. Then two 2.5‐mm distraction needles and two 4.5‐mm fixation needles are used to mount the external fixator. Five days after surgery, transversely distract the bone chip outward at a speed of 1 mm per day, divided 2 times, for 2 weeks. Stop moving for 3 days, and then compress the bone chip back at the same speed. X‐ray shall be taken 7 days after distraction to check the position of the bone chip. When the whole distraction is done, take another X‐ray film to make sure the bone chip is back to the correct position. If the wound healing is slow, it can be distracted repeatedly. If the wound is recovered, remove the external fixator directly and protect the operated limb with small splints or braces for 6–8 weeks till the corticotomy has healed on an X‐ray film.
Further simplification of the external fixator can reduce the risk of complications and reduce the impact on the patient's daily life. Surgery without using a limb tourniquet can protect the blood supply to the lower extremity to some extent. Reducing the incision and osteotomy area, emphasizing the protection of the periosteum, and using an osteotomy device to make the bone chip can reduce the damage to bone and local tissue. These improvements will not significantly increase the difficulty of surgery but contribute to wound healing and microcirculation reconstruction. It is a new method to use splints or braces after the external fixator is removed. Yang et al. 80 implemented this method and asked patients to practice partial weight‐bearing walking of the operated limb. The patient needed to be reexamined monthly, and the limb could be fully weight‐bearing after the bone chip had healed completely. Among the 20 patients with thromboangiitis obliterans, one case was amputated due to foot ischemia aggravation, and one case was amputated due to bone chip infection. No tibia fracture or other complications occurred in the rest of the patients.
Summary and Prospects
TTT technique has been used in PR China for 20 years, and the past 20 years have witnessed the transformation of this technique. It has a particular effect on the treatment of lower limb chronic ischemic diseases by reconstructing the microcirculation system. There may also be potential roles that have not yet been discovered. Due to its simple operation and short learning curve, this technique has been applied by more and more scholars. The lack of uniform standards in the past has led to differences in application, management, and even efficacy. Reports of complications have cast doubt on this invasive treatment and made it difficult for doctors and patients to understand and accept.
The publication of the “Expert Consensus on the Treatment of Diabetic Foot Ulcers Using Tibial Transverse Transport (2020)” is another milestone for the TTT technique. It will further guide the clinical application in the future so that the conclusions provided will be more reliable. At the same time, we should not just focus on the efficacy of this technique while ignoring its complications. We need to fully communicate with patients to get their understanding and cooperation so that they can have reasonable expectations and high compliance and carry out treatment under the cooperation of both doctors and patients. In the future, the mechanism of action of this technique is still worth further study, and the application fields are worth further exploration. It is also hoped that more combined therapies will bring new hope to more patients suffering from pain.
APPENDIX
Acknowledgments
All authors listed have contributed to the manuscript.
Disclosure: The authors have no conflicts of interest to disclose in relation to this article.
References
- 1. Liu Z, Xu C, Yu YK, Tu DP. Research progress of tibial transverse transport in treatment of chronic ischemic diseases of the lower extremities. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:994–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Zhu YL, Qu L, Ye ZM. Tibial cortex transverse distraction for primarily lymphoedema in the lower limb: a case report. J Orthop Translat. 2020;25:25–7. [Google Scholar]
- 3. Qu L, Wang AL, Tang FG. The therapy of transverse tibial bone transport and vessel regeneration operation on thromboangitis obliterans. Zhonghua Yi Xue Za Zhi. 2001;81:622–4. [PubMed] [Google Scholar]
- 4. Qin SH. Technical overview of Ilizarov. Zhonghua Gu Ke Za Zhi. 2006;26:642–5. [Google Scholar]
- 5. Qu L. Ilizarov's tibial transverse transport technique in the past, present and afterlife—the history of the birth of a treatment. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:951–5. [Google Scholar]
- 6. Ilizarov GA. The tension‐stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft‐tissue preservation. Clin Orthop Relat Res. 1989;238:249–81. [PubMed] [Google Scholar]
- 7. Qu L, Shi JH, Liu LL, Jin H, Guo HB, Huang DD, et al. Treatment of bone infection, bone defect and soft tissue defect by bone displacement. Zhonghua Wai Ke Za Zhi. Chin J Surg. 2004;42:1469. [Google Scholar]
- 8. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314–21. [DOI] [PubMed] [Google Scholar]
- 9. Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;34:599–610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kaplani K, Koutsi S, Armenis V, Skondra FG, Karantzelis N, Tsaniras SC, et al. Wound healing related agents: ongoing research and perspectives. Adv Drug Deliv Rev. 2018;129:242–53. [DOI] [PubMed] [Google Scholar]
- 11. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–46. [DOI] [PubMed] [Google Scholar]
- 12. Gao W. Effect of transverse bone transport on severe diabetic foot and mechanism of wound regeneration with macrophages and epidermal stem cells. Thesis, Guangxi Medical University, 2018.
- 13. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MPJ, Donners MMPC. Anti‐inflammatory M2, but not pro‐inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2014;17:109–18. [DOI] [PubMed] [Google Scholar]
- 14. Gao W, Lin ZX, Zhen PX, Chen Y, Kuang XC, Hua QK. Macrophages promote the healing of severe diabetic foot wounds after tibial transverse transport. Zhongguo Zu Zhi Gong Cheng Yan Jiu. 2018;22:5811–5. [Google Scholar]
- 15. Kasiewicz LN, Whitehead KA. Recent advances in biomaterials for the treatment of diabetic foot ulcers. Biomater Sci. 2017;5:1962–75. [DOI] [PubMed] [Google Scholar]
- 16. Lian HY, Hua QK, Chen Y, He LH, Zhuang S, Yang SJ, et al. A study of pattern and mechanism of action of wound healing of severe diabetic foot after treatment with transverse tibial bone transport surgery. Zhong Yi Zheng Gu. J Tradit Chin Orthop Trauma. 2019;31:15–9, 33. [Google Scholar]
- 17. Hu MS, Maan ZN, Wu J‐C, Rennert RC, Hong WX, Lai TS, et al. Tissue engineering and regenerative repair in wound healing. Ann Biomed Eng. 2014;42:1494–507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Clements MP, Byrne E, Camarillo Guerrero LF, Cattin AL, Zakka L, Ashraf A, et al. The wound microenvironment reprograms schwann cells to invasive mesenchymal‐like cells to drive peripheral nerve regeneration. Neuron. 2017;96:98–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Heinolainen K, Karaman S, D'Amico G, Tammela T, Sormunen R, Eklund L, et al. VEGFR3 modulates vascular permeability by controlling VEGF/VEGFR2 signaling. Circ Res. 2017;120:1414–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Boucher JM, Clark RP, Chong DC, Citrin KM, Wylie LA, Bautch VL. Dynamic alterations in decoy VEGF receptor‐1 stability regulate angiogenesis. Nat Commun. 2017;8:1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Yu Z, Witman N, Wang W, Li D, Yan B, Deng M, et al. Cell‐mediated delivery of VEGF modified mRNA enhances blood vessel regeneration and ameliorates murine critical limb ischemia. J Control Release. 2019;310:103–14. [DOI] [PubMed] [Google Scholar]
- 22. Ou SJ, Xu CP, Li GT, Sun H, Yang Y, Lu H, et al. Effect of transverse tibial bone transport on expression of serum angiogenesis‐related growth factors. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:98–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Przybylski M. A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care. 2009;18:516–9. [DOI] [PubMed] [Google Scholar]
- 24. Barrientos S, Brem H, Stojadinovic O, Tomic‐Canic M. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen. 2014;22:569–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Hua QK, Qin SH, Kuang XC, Chen Y, Qu L, Zhao JM. Treatment experiences of 516 cases of diabetic foot treated with tibial transverse transport. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:959–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Cen ZX, Zeng GF, He JC, Gao YB, Cao BC, Zhang CY, et al. Advanced bone transport for diabetic foot. Zhongguo Zu Zhi Gong Cheng Yan Jiu. J Clin Rehabil Tis Eng Res. 2018;22:5766–71. [Google Scholar]
- 27. Zhao XM, Liu L, Jia ZW, Yuan QL, Shi YM, Zhang YG. Clinical observation of the treatment of diabetic foot with transverse tibial bone transport. Xi'an Jiaotong Da Xue Xue Bao. 2020;41:244–50. [Google Scholar]
- 28. Xiang J. Effects of transverse tibial bone transport on colony forming of hematopoietic stem cell and PI3K/AKT signaling pathway in diabetic foot. Thesis, Guangxi Medical University, 2018.
- 29. Lian HY. Investigating the role of stem cell mobilization on the mechanism of severe and resistant diabetic foot ulcers treated by tibial corticotomy followed by transverse distraction. Thesis, Guangxi Medical University, 2019.
- 30. Anh Vu Le Hoang Tibial transverse transport (TTT) for treatment of severe diabetic foot and the mechanism research of the bone marrow stem cell mobilization. Thesis, Guangxi Medical University, 2017.
- 31. Wang B, Yang YG. A case of femoral artery bypass grafting combined with transversal bone transfer of tibia in the treatment of arteriosclerosis obliterans. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015;29:1188. [Google Scholar]
- 32. Hua QK, Wang L, Xian C, Zhao JM. The clinical effect of Ilizarov microcirculation reconstruction in the treatment of chronic ischemic disease of lower extremity. Zhongguo Jiao Xing Wai Ke Za Zhi. 2015;23:2007–11. [Google Scholar]
- 33. Xian C, Zhao JM, Su W, Lao S, Yang X, Hua QK. Ilizarov bone transport for repair of diabetic foot: a functional and imaging evaluation. Zhongguo Zu Zhi Gong Cheng Yan Jiu. 2015;19:7539–44. [Google Scholar]
- 34. Zhang DW, Zang JC, Wang ZJ, Qin SH. Patients with diabetic foot ulcers treated with the ilizarov microcirculation reconstruction technique. Yi Xue Yu Zhe Xue. 2015;36:19, 26. [Google Scholar]
- 35. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta‐analysis. Ann Med. 2017;49:106–16. [DOI] [PubMed] [Google Scholar]
- 36. Dai Y, Zhang RP, Wang H, Zhang H, Li W, Wang XJ. Clinical observation of autologous peripheral blood stem cell transplantation in the treatment of chronic ischemic diseases of lower limbs. Zhongguo Yi Yao Zhi Nan. 2019;17:17–8. [Google Scholar]
- 37. Yang KB, Jiang TJ, Chen L, Yao L, Liang MH. Curative effect observation on transverse bone movement of the tibia for the treatment of chronic ulcers in the elderly. Jilin Yi Xue. 2020;41:787–9. [Google Scholar]
- 38. Nie X, Kuang X, Liu G, Zhong Z, Ding Y, Yu J, et al. Tibial cortex transverse transport facilitating healing in patients with recalcitrant non‐diabetic leg ulcers. J Orthop Translat. 2021;27:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Lentz R, Shin C, Bloom Z, Yamada K, Hong YK, Wong AK, et al. From bench to bedside: the role of a multidisciplinary approach to treating patients with lymphedema. Lymphat Res Biol. 2021;19:11–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Patwa JJ, Krishnan A. Buerger's disease (thromboangiitis obliterans)‐ management by Ilizarov's technique of horizontal distraction. A retrospective study of 60 cases. Indian J Surg. 2011;73:40–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Kulkarni S, Kulkarni G, Shyam AK, Kulkarni M, Kulkarni R, Kulkarni V. Management of thromboangiitis obliterans using distraction osteogenesis: a retrospective study. Indian J Orthop. 2011;45:459–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Chen Y, Kuang X, Zhou J, Zhen P, Zeng Z, Lin Z, et al. Proximal tibial cortex transverse distraction facilitating healing and limb salvage in severe and recalcitrant diabetic foot ulcers. Clin Orthop Relat Res. 2020;478:836–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Xian C, Zhao JM, Su W, Lao S, Hua QK. Clinical observation on the treatment of diabetic foot by transversebone displacement and microcirculation regeneration of tibia. Guangxi Yi Ke Da Xue Xue Bao. 2015;32:605–7. [Google Scholar]
- 44. Li G, Ling SKK, Li HA, Zhang Y, Hu J. How to perform minimally invasive tibial cortex transverse transport surgery. J Orthop Translat. 2020;25:28–32. [Google Scholar]
- 45. Xu YD, Xu YE, Zhou MW, An GY, Chen, et al. Research progress in the molecular mechanism of accordion technique for bone nonunion. Zhongguo Jiao Xing Wai Ke Za Zhi. 2020;28:1288–92. [Google Scholar]
- 46. Shen J, Ye XJ. Effect of “accordion” technique on bone consolidation during distraction osteogenesis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018;32:558–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Yang K, Ding XF, Wang YL, Yan ZG, Shen JC, Ji KY, et al. Nursing experience of treating diabetic foot with tibial transverse transport technique. Zu Huai Wai Ke Dian Zi Za Zhi. J Foot Ankle Surg. 2017;4:53–5. [Google Scholar]
- 48. Yang SY, Zhu SY, Mo SQ, Wang FF. Efficacy analysis of tibial bone transport in the treatment of thromboangiitis obliterans. Zhongguo Jiao Xing Wai Ke Za Zhi. 2017;25:2201–3. [Google Scholar]
- 49. Ou SJ, Qi Y, Sun HT, Xu CP, Lu HY, li WJ, et al. Percutaneous minimally invasive tibial osteotomy and transverse bone transport for diabetic foot. Zhongguo Jiao Xing Wai Ke Za Zhi. Orthop J China. 2018;26:1385–9. [Google Scholar]
- 50. Cheng Q, Qiu Y, Shi NW. Clinical effect of transversebone translocation of tibia in the treatment of chronic ischemic disease of lower limbs. Heilongjiang Yi Xue. 2018;42:663–4, 666. [Google Scholar]
- 51. Jia ZW, Yu JP, Su YX, Guo XS, Yu JB, Yang ZJ, et al. Clinical efficacy analysis of transverse tibial bone transport combined with vacuum drainage for the treatment of diabetic foot ulcer. Zhongguo Gu Shang. 2018;31:232–6. [DOI] [PubMed] [Google Scholar]
- 52. Choi IH, Chung CY, Cho T‐J, Yoo WJ. Angiogenesis and mineralization during distraction osteogenesis. J Korean Med Sci. 2002;17:435–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Cao XJ, Jia ZW, Guo XS, Wang XD, Yu JP, et al. Experimental study on the improvement of Ilizarov transverse tibial bone transport and microcirculation reconstruction technique. Zhonghua Yi Xue Za Zhi. 2019;99:3592–6. [DOI] [PubMed] [Google Scholar]
- 54. Li Z, Ling JS, Wang PR, Niu JK, Li QD, He XS, et al. Analysis of the treatment of severe lower limb arterial vascular lesions of diabetic foot with Ilizarov transverse tibial bone transport technique combined with interventional methods. Zhongguo Lin Chuang Xin Yi Xue. Chin Med J. 2020;13:1108–12. [Google Scholar]
- 55. Zhang DW, Qin SH, Zang JC. Clinical effect analysis of Ilizarov microcirculation reconstruction technique in treatment of Wagner grade 4 diabetic foot. Zhongguo Jiao Xing Wai Ke Za Zhi. 2017;25:354–6. [Google Scholar]
- 56. Cheng Q, Sun X, Qiu Y, Shi NW. Transversebone displacement in the treatment of diabetic foot: a case. Heilongjiang Yi Xue. 2018;42:73–5. [Google Scholar]
- 57. Liu XD, You MR, Gan HR, Dong XP. 3D printed guide plate guided transverse‐bone transfer of tibia for the treatment of diabetic foot. Jiangxi Yi Yao. 2018;53:1359–61, 1379. [Google Scholar]
- 58. Wang B, Liu W, Huo YX, Gong Z, Wang W, Hao R, et al. Application of femoral‐femoral artery bypass grafting combined with transverse tibial bone transporting for lower extremity arteriosclerosis obliterans or combined with diabetic foot. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018;32:1576–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Ding XF, Xu LH, Wang YL, Yang K, Shen JC, Ji KY. Clinical observation of diabetic foot treated with transverse tibial bone transport microcirculation reconstruction technology. Hua Nan Guo Fang Yi Xue Za Zhi. 2018;32:628–31. [Google Scholar]
- 60. Zhou Q. CTA to evaluate the clinical effect of lateral tibial bone transfer in the treatment of elderly diabetic foot. Ying Xiang Yan Jiu Yu Yi Xue Ying Yong. 2018;2:154–6. [Google Scholar]
- 61. Sun Y, Xiao YG, Wang H. Transverse tibial bone movement for the treatment of diabetic foot ulcers. Zhongguo Gu Shang. 2018;31:949–52. [DOI] [PubMed] [Google Scholar]
- 62. Ye F, Xu HB, Shen K, Wang RL. Lateral tibia bone removal method of treatment of thromboangiitis obliterans of lower limbs curative effect analysis. Zhongguo Yao Wu Yu Lin Chuang. 2018;18:2205–6. [Google Scholar]
- 63. Wang B, Liu W, Gong ZP, Wang W, Hao R, Tu Z, et al. Study on vascular selection and pre‐reconstruction in tibial transverse transport. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:1579–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Zhao W, Lu ZC, Wang XD, Yang MW. Interventional therapy combined with transverse tibial bone transport for ischemic disease of lower limbs. Zhongguo Jiao Xing Wai Ke Za Zhi. 2019;27:809–14. [Google Scholar]
- 65. Lu YZ, Wu YD, Wu CQ, Ding L, Qin D, Wang JG. Tibial transverse transport combined with vacuum sealing drainage for diabetic foot ulcers. Zhongguo Jiao Xing Wai Ke Za Zhi. 2021;29:46–50. [Google Scholar]
- 66. Liang B, Chen J, Chen GM, Cai JS, Chen QX, Ruan GQ. Analysis of clinical efficacy of tibial transverse bone transport combined with negative pressure drainage on diabetic foot. Zhonguo Shi Yong Yi Yao. 2020;15:50–2. [Google Scholar]
- 67. Wang D, Zhang YH, He GY, Zhang XD, Qin SH. Clinical study on treatment of chronic infection of foot and ankle with lower extremity ischemic diseases by tibial transverse transport combined with antibiotic embedded bone cement. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:979–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Wu YP. Autologous platelet‐rich plasma combined with transverse tibial bone transport by Ilizarov technique for treating diabetic foot ulcers. Han Shao Jian Ji Bing Za Zhi. 2021;28:63–4. [Google Scholar]
- 69. Yao KW, Zhang LC. Clinical effect of transverse bone transport combined with autologous platelet rich in the treatment of diabetic foot. Lin Chuang He Li Yong Yao Za Zhi. 2020;13:133–4. [Google Scholar]
- 70. He YX, Chen YX, Xu Y, Guo YS, Tian LJ, Liu PL. Effect of transverse bone transfer technique combined with PRP on serum factor in diabetic foot patients. Hebei Yi Ke Da Xue Xue Bao. 2020;41:940–3. [Google Scholar]
- 71. Wang JB. Clinical observation of Qigui Tongluo decoction combined with Ilizarov technique for transverse tibial bone removal in the treatment of diabetic foot. Zhongguo Min Jian Liao Fa. 2020;28:84–6. [Google Scholar]
- 72. Zhao XM, Zhang YG. Clinical effect of postoperative combined with Mudan granule on diabetic foot patients undergoing tibial lateral bone transfer. Zhonghua Quan Ke Yi Xue. 2020;18:533–6,650. [Google Scholar]
- 73. Xu XZ, Wang AL, Jing DM. Vessel regeneration by tibial bone immigration on the thromboangiitis obliterans: an analysis of 35 cases. Zhongguo Shi Yong Wai Ke Za Zhi. 2011;31:523–4. [Google Scholar]
- 74. Hu Z, Wu YY, Zhou SD, Wu XY. Analysis of therapeutic effect of transverse tibial bone transport technique for thromboangiitis obliterans. Zhe Jiang Chuang Shang Wai Ke. 2018;23:1201–3. [Google Scholar]
- 75. Tian L, Shi XQ, Duan ZL, Wang K, Zhang L, Wang PM. Efficacy and safety of transverse tibial bone transport technique in the treatment of diabetic foot: a meta‐analysis. Zhongguo Zu Zhi Gong Cheng Yan Jiu. 2021;25:3275–80. [Google Scholar]
- 76. Zhang DW, Huang JQ, Shi B, Chen B. Analysis of complications in diabetic foot treated with tibial transverse transport. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:985–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Qin CH, Zhou CH, Zhang HA, Lin QR, Cao Y, Luo XR, et al. Observation on the curative effect of transverse tibial bone transport in the treatment of diabetic foot. Zhongguo Jiao Xing Wai Ke Za Zhi. Orthop J China. 2019;27:1809–12. [Google Scholar]
- 78. Fan ZQ, Yu ZH, Zheng JZ, Yu BF, Liu DW. Tibial cortex transverse distraction in treating diabetic foot ulcers: what are we concerned about? J Int Med Res. 2020;48:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Zhao JM, Li G. Expert consensus on the treatment of diabetic foot ulcers using tibial transverse transport (2020). Zhong Guo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34:945–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Yang SJ, Chen Y, Kuang XC, Zhuang S, He LH, Zhen PX, et al. Treatment of lower extremity thromboangiitis obliterans with transverse tibial bone transfer. Zhong Yi Zheng Gu. J Tradit Chin Orthop Traumatol. 2020;32:58–61. [Google Scholar]